SGEN

Seattle Genetics, Inc. News Headlines

$31.16
*  
0.34
1.08%
Get SGEN Alerts
*Delayed - data as of Jan. 30, 2015  -  Find a broker to begin trading SGEN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Earnings Peek: Market Seems Determined To Keep Seattle Genetics In The $30s
1/26/2015 1:20:00 PM - Seeking Alpha


First Week of SGEN September 18th Options Trading
1/23/2015 12:20:35 PM - BNK Invest


Commit To Buy Seattle Genetics At $25, Earn 8.5% Annualized Using Options
1/21/2015 11:55:49 AM - BNK Invest


ALPS Puts Twist On Biotech Investing With Medical Breakthrough ETF
1/15/2015 12:48:00 AM - Seeking Alpha


Eli Lilly Inks Oncology Deals with Merck, Bristol-Myers - Analyst Blog
1/14/2015 5:35:00 PM - Zacks.com


Eli Lilly Inks Oncology Deals with Merck, Bristol-Myers - Analyst Blog
1/14/2015 5:35:00 AM - Investopedia


Seattle Genetics, Bristol-Myers to Study Adcetris-Opdivo - Analyst Blog
1/13/2015 5:46:00 PM - Zacks.com


Seattle Genetics, Bristol-Myers to Study Adcetris-Opdivo - Analyst Blog
1/13/2015 5:46:00 AM - Investopedia


Seattle Genetics To Present At J.P. Morgan Conference ; Webcast At 2:30 PM ET
1/12/2015 1:30:00 PM - RTT News


Seattle Genetics, Bristol-Myers Report Clinical Trial Collaboration
1/12/2015 8:18:00 AM - RTT News


Why Seattle Genetics, Inc. Stock Dove 12% in December
1/8/2015 11:03:02 AM - Motley Fool


Public Shame for Biotechs Not Webcasting 'JPM15' Breakout Sessions
1/6/2015 3:08:00 PM - TheStreet


New Biotech ETF From ALPS
1/2/2015 8:05:16 AM - Benzinga


Bull of the Day: Incyte (INCY) - Bull of the Day
1/1/2015 1:00:00 PM - Investopedia


Seattle Genetics And Agios Pharmaceuticals: Opportunity Or Danger?
12/23/2014 11:21:00 AM - Seeking Alpha


Seattle Genetics Initiates Phase Ib Study on Leukemia Drug - Analyst Blog
12/19/2014 11:20:00 AM - Investopedia


Seattle Genetics Initiates Phase Ib Study on Leukemia Drug - Analyst Blog
12/19/2014 11:20:00 AM - Zacks.com


Zacks' Bull Of The Day: Seattle Genetics
12/19/2014 9:14:00 AM - Seeking Alpha


Bull of the Day: Seattle Genetics (SGEN) - Bull of the Day
12/19/2014 1:00:00 AM - Zacks.com


Seattle Genetics: Good Tech, But On The Wrong Path
12/18/2014 6:42:00 PM - Seeking Alpha


Bull of the Day: Seattle Genetics (SGEN) - Bull of the Day
12/18/2014 1:00:00 PM - Investopedia


InsiderInsights.com Daily Round Up 12/17/14: HTZ, NAV, ENH, AIRT
12/18/2014 4:35:00 AM - Seeking Alpha


Dow 30 Stock Roundup: Chevron Acquires New Zealand Exploration Rights, Merck Announces Positive Keytruda Study Results - Analyst Blog
12/12/2014 2:12:00 PM - Zacks.com


InsiderInsights.com Daily Round Up 12/10/14: PSEC, TWI, SGEN, ATLS
12/11/2014 1:18:00 AM - Seeking Alpha


Seattle Genetics Is Offering Growth, For A Price
12/10/2014 1:06:00 PM - Seeking Alpha